NM_152473.3:c.175T>A
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_152473.3(ERVV-1):c.175T>A(p.Tyr59Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. 10/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_152473.3 missense
Scores
Clinical Significance
Conservation
Publications
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 17
GnomAD4 exome Data not reliable, filtered out with message: AS_VQSR AF: 0.00000198 AC: 2AN: 1011140Hom.: 0 Cov.: 15 AF XY: 0.00000198 AC XY: 1AN XY: 504402 show subpopulations ⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
GnomAD4 genome Cov.: 17
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.175T>A (p.Y59N) alteration is located in exon 1 (coding exon 1) of the ERVV-1 gene. This alteration results from a T to A substitution at nucleotide position 175, causing the tyrosine (Y) at amino acid position 59 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at